Pulmonary Arterial Hypertension is consistantly high blood pressure in the pulmonary artery.
Hi everyone. I recently joined RareShare due to my T-Cell LGL diagnosis and stumbled upon drnezin's profile a few minutes ago to discover the PAH community. Wow! I was diagnosed with PAH in summer '08. First, I was on Ventavis (iloprost) inhale solution for one year which worked fine before switching to the newest Tyvaso inhale solution. I have been on Tyvaso ever since and doing well considering everything. For having the T-Cell LGL leukemia just recently, my priorities in fighting my complicated health challenges have shifted dramatically. However, I'm keeping a close eye on PAH as well. In fact, there is a potential connection b/w the two as I have recently heard. I would be delighted to chat with anyone with this condition.
Hi Ammy, no I have no experience with htis drug. sorry. I pray you have good results. Barbara
My Cardiologist prescribed Generic accuretic 12.5MG for treatment of high blood pressure (hypertension). He's said reducing high blood pressure helps prevent strokes, heart attacks, and kidney problems. Any experience about this medication.
HI All, so what is everyone's story? I have been diagnosised with PH for 2 years. I have the secondary type caused by my Interstitial Lung Disease. . Happy Spring. Barbara
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.FIND YOUR COMMUNITY
Our rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.